SCREENING OF GROUP B STREPTOCOCCUS AGALACTIAE AMONG PREGNANT WOMEN IN DUHOK CITY/ KURDISTAN REGION/ IRAQ

DIYAR MOHAMMED TAHER ALI; ABDULRAHMAN TOWFEEQ SAADI

DIYAR MOHAMMED TAHER ALI Department of Laboratories, Azadi Teaching Hospital, University of Duhok, Kurdistan Region of Iraq.
ABDULRAHMAN TOWFEEQ SAADI Assist. Professor, Medical Microbiology, College of Medicine, University of Duhok, Kurdistan Region of Iraq

Keywords: Antibiotic and Vitek-2, High Vaginal Swabs (HVS), Kirby-Bauer disk diffusion, Risk factors, Streptococcus agalactiae-Group B Streptococci (GBS)

Abstract

https://doi.org/10.31386/dmj.2023.17.1.1

Background: Pregnant women colonized with Streptococcus agalactiae-Group B Streptococci (GBS) can transmit the bacteria to their new-borns at the time of birth. Intrapartum antibiotic prophylaxis (IAP) can prevent this transmission. The aim of this study is to find out the carriage rate of group B streptococci isolated from pregnant women in Duhok city, Iraq. Other aim is to study the Antibiotic susceptibility patterns of the isolates and to detect the risk factors associated with the growth of these bacteria.

Methods: Exactly 821 pregnant women living in Duhok city were randomly screened for GBS colonization, over a period of 7 months from 1st of January, 2022 till 1st of August, 2022. High vaginal swabs (HVS) sample were collected, processed and identification was performed by Vitek system 2. The isolated strains of GBS were selected for in vitro susceptibility testing. As well as also risk factors associated with infection were assessed.

Results: GBS was detected in 37/821 accounted (4.51%) pregnant women. Risk factors such as vaginal discharge, UTI, Diabetes, abortions and still birth did not show major differences between positive and negative cases of GBS. Pencillin G, Co-Amoxiclav, Nitrofurantoin, Vancomycin and Ampiciilin have shown the highest sensitivity percentages (93.9%, 93.8%, 88.9%, 87.5% and 84% respectively). The sensitivity rate for other B-Lactams: Cepholothin, Ceftriaxone and Cefixim were: 70.6%, 63% and 78% respectively. The sensitivity for Gentamicin was 38.9% and 48.4% for Ciprofloxacin. However, the lowest sensitivity rates were detected for Clindamycin, Amikacin and Erythromycin: 26.1%, 30% and 30.5% respectively.

Conclusions: Carriage rates of GBS among pregnant women in this setting are still low-grade. Penicillin and Ampicillin are the drugs of choice (intra-partum prophylaxis) against GBS in pregnancy. Co-amoxiclave and Vancomycin also had a high level of sensitivity.

Downloads

Download data is not yet available.

References

1. Gao, K., Deng, Q., Huang, L., Chang, C., Zhong, H., Xie, et,al. Diagnostic Performance of Various Methodologies for Group B Streptococcus Screening in Pregnant Woman in China. Frontiers in Cellular and Infection Microbiology.2021;11.
2. What are the risks of group B streptococcus (GBS) infection during pregnancy? [online] Available at: 3. Nadeau, H. and Edwards, R. Prophylaxis Against Early-onset Group B Streptococcus Infections in Pregnant Women Who Are Allergic to Penicillin. Clinical Obstetrics & Gynecology.2019; 62(4): 771-780.
4. Furfaro, L., Chang, B. and Payne, M. Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets. Clinical Microbiology Reviews.2018; 31 (4)
5. Raabe, V. and Shane, A. Group B Streptococcus(Streptococcus agalactiae). Microbiology Spectrum. 2019; 7(2)
6. Kidshealth.org. 2022. Group B Strep and Pregnancy (for Parents) - Nemours Kids Health. [online] Available at: [Accessed 18 May 2022].
7. Flores-Mireles, A., Walker, J., Caparon, M. and Hultgren, S. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology. 2015; 13(5): 269-284.
8. Committee Opinion No. 485: Prevention of Early-Onset Group B Streptococcal Disease in Newborns. 2022.
9. Baker, C., n.d. Red book atlas of pediatric infectious diseases. NHS.UK. 2022.
10. Obstetrics & Gynecology. The American College of Obstetricians and Gynecologists. 2019; 134(1): 1-1.
11. Salama, K., Gad, A. and El Tatawy, S. Sepsis profile and outcome of preterm neonates admitted to neonatal intensive care unit of Cairo University Hospital.2022.
12. JR, V., L, M. and SJ, S. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. [online] PubMed. Available at: [Accessed 25 April 2022].
13. Kohli-Lynch, M., Russell, N., Seale, A., Dangor, Z., Tann, Et,al. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses. Clinical Infectious Diseases, 2017; 65(suppl_2): S190-S199.
14. Cleveland Clinic. Group B Strep In Pregnancy: Test, Risks & Treatment. [online] Available at: [Accessed 27 August 2022].
15. Dilrukshi, G., Kottahachchi, J., Dissanayake, D., Pathiraja, R., Karunasingha, J., Sampath, M., et, al, Group B Streptococcus colonisation and their antimicrobial susceptibility among pregnant women. 2020.
16. Obstetrics & Gynecology. Prevention of Group B Streptococcal Early Onset Disease in New-borns: 2020; 135(2): e51-e72.
17. Faro, J., Bishop, K., Riddle, G., Ramirez, M., Katz, A., Turrentine, M. and Faro, S. Accuracy of an Accelerated, Culture-Based Assay for Detection of Group B Streptococcus. Infectious Diseases in Obstetrics and Gynecology: 2013; 1-4.
18. Humphries, R., Bobenchik, A., Hindler, J. and Schuetz, A. Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. Journal of Clinical Microbiology: 2021; 59(12).
19. Abbey, T. and Deak, E. What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing M100, 29th Edition: Clinical Microbiology Newsletter, 2019; 41(23): 203-209.
20. Woldu, Z., Teklehaimanot, T., Waji, S. and Gebremariam, M. The prevalence of Group B Streptococus recto-vaginal colonization and antimicrobial susceptibility pattern in pregnant mothers at two hospitals of Addis Ababa: Ethiopia. Reproductive Health: 2014; 11(1).
21. Barbaros, I., Murat, C., Mehmet, V., Ismet, T., Can, K., Sukufe, D., Ismail, C. and Yildiz, P. The colonization incidence of group B streptococcus in pregnant women and their new-borns in Istanbul: Paediatrics International, 2005; 47(1): 64-66.
22. Lu, B., Li, D., Cui, Y., Sui, W., Huang, L. and Lu, X. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China. Clinical Microbiology and Infection, 2014; 20(6): O370-O373.
23. Melo, S., Costa, A., Silva, F., Silva, N., Tashima, C., Cardoso, R, et al.. Prevalence of Streptococcus agalactiae colonization in pregnant women from the 18th Health Region of Paraná State: Revista do Instituto de Medicina Tropical de São Paulo, 2018; 60(0).
24. Assefa, S., Desta, K. and Lema, T. Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia. BMC Pregnancy and Childbirth, 2018; 18(1).
25. Zaki, D. and Hamed, Z. Molecular and Bacteriological Characterization of Local Group B Streptococci (GBS) in some Iraqi Pregnant Women: [online] Available at: 2014; [Accessed 30 August 2022].
26. Lu, B., Li, D., Cui, Y., Sui, W., Huang, L. and Lu, X. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China. Clinical Microbiology and Infection,2014; 20(6): O370-O373.
27. NevioCimolai and Tomas Cimolai. Nitrofurantoin and pregnancy: 2007; 176: 1860-1861.